Literature DB >> 26590368

Alterations to prepulse inhibition magnitude and latency in adult rats following neonatal treatment with domoic acid and social isolation rearing.

Amber L Marriott1, R Andrew Tasker2, Catherine L Ryan3, Tracy A Doucette3.   

Abstract

Deficits in perceptual, informational, and attentional processing are consistently identified as a core feature in schizophrenia and related neuropsychiatric disorders. Neonatal injections of low doses of the AMPA/kainate agonist domoic acid (DOM) have previously been shown to alter various aspects of perceptual and attentional processing in adult rats. The current study investigated the effects of combined neonatal DOM treatment with isolation rearing on prepulse inhibition behaviour and relevant neurochemical measures, to assess the usefulness of these paradigms in modeling neurodevelopmental disorders. Daily subcutaneous injections of DOM (20 μg/kg) or saline were administered to male and female rat pups from postnatal days (PND) 8-14. After weaning, rats were either housed alone or in groups of 4. Both the magnitude and latency of prepulse inhibition were determined in adulthood (approximately 4.5 months of age) and post-mortem brain tissue was assayed using Western blot. Social isolation alone significantly lowered PPI magnitude in male (but not female) rats while DOM treatment appeared to make animals refractory to this effect. Combining social isolation and DOM treatment caused an additive decrease in PPI startle latency. No statistically significant differences were found in the expression of D1, D2, TH, GAD65 or GAD67 protein in either the prefrontal cortex or hippocampus, although some tendencies toward differences were noted. We conclude that both neonatal low-dose DOM and social isolation affect prepulse inhibition in rats but that each paradigm exerts these effects through different neuronal signalling systems.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Domoic acid; Isolation rearing; Neurodevelopmental disorders; Prepulse inhibition; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26590368     DOI: 10.1016/j.bbr.2015.11.009

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

Review 1.  Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.

Authors:  Asma Khan; Susan B Powell
Journal:  Schizophr Res       Date:  2017-10-22       Impact factor: 4.939

2.  Altered Auditory Processing, Filtering, and Reactivity in the Cntnap2 Knock-Out Rat Model for Neurodevelopmental Disorders.

Authors:  Kaela E Scott; Ashley L Schormans; Katharine Y Pacoli; Cleusa De Oliveira; Brian L Allman; Susanne Schmid
Journal:  J Neurosci       Date:  2018-08-20       Impact factor: 6.167

3.  Progressive changes in hippocampal cytoarchitecture in a neurodevelopmental rat model of epilepsy: implications for understanding presymptomatic epileptogenesis, predictive diagnosis, and targeted treatments.

Authors:  Paul B Bernard; Leslie A Ramsay; Debra S MacDonald; R Andrew Tasker
Journal:  EPMA J       Date:  2017-08-29       Impact factor: 6.543

Review 4.  Public health risks associated with chronic, low-level domoic acid exposure: A review of the evidence.

Authors:  Rebekah Petroff; Alicia Hendrix; Sara Shum; Kimberly S Grant; Kathi A Lefebvre; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2021-04-28       Impact factor: 12.310

Review 5.  Silence, Solitude, and Serotonin: Neural Mechanisms Linking Hearing Loss and Social Isolation.

Authors:  Sarah M Keesom; Laura M Hurley
Journal:  Brain Sci       Date:  2020-06-12

6.  Calbindin Deficits May Underlie Dissociable Effects of 5-HT6 and mGlu7 Antagonists on Glutamate and Cognition in a Dual-Hit Neurodevelopmental Model for Schizophrenia.

Authors:  Sinead E Shortall; Angus M Brown; Eliot Newton-Mann; Erin Dawe-Lane; Chanelle Evans; Maxine Fowler; Madeleine V King
Journal:  Mol Neurobiol       Date:  2020-06-12       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.